India’s first National IPR Policy maintains position on affordable drugs

May 31 2016

The India government has unveiled the first National Intellectual Property Rights Policy that sets out seven objectives and relevant guidelines to promote the country’s IP regime, and has resisted pressure from the United States to amend the patent law regarding access to cheap drugs

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

more from across site and SHARED ros bottom lb

More from across our site

Patents

‘Watershed moment’: India’s top court to decide competition jurisdiction over patents

Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come

Sukanya Sarkar, February 03 2026

Patents

Finnegan team secures $240m jury verdict after PTAB success

Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast

Sanjana Mishra, February 03 2026

Trademarks

Fame in the age of fakes: How celebrities are fighting AI impersonation with IP law

After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image

Deborah Kirk, February 03 2026

Patents

Dolby and IP Bridge sue Skyworth in Brazil

The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue

Sanjana Mishra, February 02 2026

Trademarks

Double exposure Close up of rows of coins for finance and banking concept Coin finance investment diagram Savings for a growing business city background with coins is popular.

Stobbs reports 1,700% profit hike after previous £1m fall

The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry

February 02 2026

Patents

Clinical trial medicine, for the covid-19 coronavirus, on clipbo

Clinical trial protocols disclosed without results: a threat to patent novelty?

In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date

Gabrielle Faure-André , February 02 2026

Patents